[Federal Register Volume 59, Number 63 (Friday, April 1, 1994)] [Unknown Section] [Page 0] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 94-7731] [[Page Unknown]] [Federal Register: April 1, 1994] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Manufacturer of Controlled Substances; Application Pursuant to Sec. 1301.43(a) of title 21 of the Code of Federal Regulations (CFR), this is notice that on January 14, 1994, MD Pharmaceutical, Inc., 3501 West Garry Avenue, Santa Ana, California 92704, made application to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below: ------------------------------------------------------------------------ Drug Schedule ------------------------------------------------------------------------ Methylphenidate (1724).................................... II Diphenoxylate (9170)...................................... II ------------------------------------------------------------------------ Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the above application and may also file a written request for a hearing thereon in accordance with 21 CFR 1301.54 and in the form prescribed by 21 CFR 1316.47. Any such comments, objections, or requests for a hearing may be addressed to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than May 2, 1994. Dated: March 21, 1994. Gene R. Haislip, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 94-7731 Filed 3-31-94; 8:45 am] BILLING CODE 4410-09-M